Femasys Inc. Depreciation Expense on Reclassified Assets
Femasys Inc. (FEMY) reported Depreciation Expense on Reclassified Assets of $295.86 thousand for the 12-month period ending 2025-12-31, per its 10-K filed 2026-03-31.
Financial Statements › Expense Statement › Operating Expenses
us-gaap:DepreciationExpenseOnReclassifiedAssets · last filed 2026-03-31
- Femasys Inc. depreciation expense on reclassified assets for fiscal 2025 was $295.86K, a 6.74% increase from fiscal 2024.
- Femasys Inc. depreciation expense on reclassified assets for fiscal 2024 was $277.18K, a 40.82% decline from fiscal 2023.
- Femasys Inc. depreciation expense on reclassified assets for fiscal 2023 was $468.39K, a 10.12% decline from fiscal 2022.
- Femasys Inc. depreciation expense on reclassified assets for fiscal 2022 was $521.15K, a 2.14% decline from fiscal 2021.
| Period end | Depreciation Expense on Reclassified Assets 12 month |
|---|---|
| 2025-12-31 | $295.86K 10-K · filed 2026-03-31 |
| 2024-12-31 | $277.18K 10-K · filed 2026-03-31 |
| 2023-12-31 | $468.39K 10-K · filed 2025-03-27 |
| 2022-12-31 | $521.15K 10-K · filed 2024-03-28 |
| 2021-12-31 | $532.55K 10-K/A · filed 2023-07-24 |
| 2020-12-31 | $542.52K 10-K · filed 2022-03-24 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| RETRACTABLE TECHNOLOGIES INC (RVP) | United States | $0.021B | -6.44 |
| HeartBeam, Inc. (BEAT) | United States | $0.022B | -2.08 |
| Modular Medical, Inc. (MODD) | United States | $0.018B | -0.88 |
| SeaStar Medical Holding Corp (ICU) | United States | $0.015B | -1.14 |
| CERENOME, INC. (CNSY) | United States | $0.014B | |
| ACCURAY INC (ARAY) | United States | $0.027B | -0.63 |
| Glucotrack, Inc. (GCTK) | United States | $0.027B | |
| Sintx Technologies, Inc. (SINT) | United States | $0.012B | -1.10 |
| NEUROONE MEDICAL TECHNOLOGIES Corp (NMTC) | United States | $0.012B | |
| Picard Medical, Inc. (PMI) | United States | $0.011B | -0.01 |